Marco Soriani, is a cellular microbiologist with more than 25 years in the field of infectious disease and vaccines. Currently, he acts as Project Director at Reithera (Rome, Italy), where he leads the Project Management Office. Regarding his scientific background, after qualifying in Biology at La Sapienza University in Rome, he studied for a doctoral degree in Biochemistry at the University of Zurich. In 1996, he began a post-doctoral tenure at the Swiss Institute for Experimental Cancer Research, Epalinges (Switzerland) and then moved to UK as a researcher at the University of Bristol (UK). In 2002, he joined Rino Rappuoli’s team at the Vaccine Research Centre in Siena. During this period, he has built a prestigious career in the vaccine field, reaching important achievements from the discovery on novel vaccine candidates to the direction of scientific programs. Marco Soriani is author of more than sixty scientific papers in high-ranking international journals and he has been in the board of several EU projects, also acting as Vice Chair for the European Research Executive Agency.